Selected Financial Data
since 2005
Income Statement
Pfizer Inc., selected items from income statement, long-term trends
US$ in millions
| 12 months ended: | Revenues | Net income attributable to Pfizer Inc. |
|---|---|---|
| Dec 31, 2023 | 58,496) | 2,119) |
| Dec 31, 2022 | 100,330) | 31,372) |
| Dec 31, 2021 | 81,288) | 21,979) |
| Dec 31, 2020 | 41,908) | 9,616) |
| Dec 31, 2019 | 51,750) | 16,273) |
| Dec 31, 2018 | 53,647) | 11,153) |
| Dec 31, 2017 | 52,546) | 21,308) |
| Dec 31, 2016 | 52,824) | 7,215) |
| Dec 31, 2015 | 48,851) | 6,960) |
| Dec 31, 2014 | 49,605) | 9,135) |
| Dec 31, 2013 | 51,584) | 22,003) |
| Dec 31, 2012 | 58,986) | 14,570) |
| Dec 31, 2011 | 67,425) | 10,009) |
| Dec 31, 2010 | 67,809) | 8,257) |
| Dec 31, 2009 | 50,009) | 8,635) |
| Dec 31, 2008 | 48,296) | 8,104) |
| Dec 31, 2007 | 48,418) | 8,144) |
| Dec 31, 2006 | 48,371) | 19,337) |
| Dec 31, 2005 | 51,298) | 8,085) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Pfizer Inc., selected items from assets, long-term trends
US$ in millions
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2023 | 43,333) | 226,501) |
| Dec 31, 2022 | 51,259) | 197,205) |
| Dec 31, 2021 | 59,693) | 181,476) |
| Dec 31, 2020 | 35,067) | 154,229) |
| Dec 31, 2019 | 32,803) | 167,489) |
| Dec 31, 2018 | 49,926) | 159,422) |
| Dec 31, 2017 | 41,141) | 171,797) |
| Dec 31, 2016 | 38,949) | 171,615) |
| Dec 31, 2015 | 43,804) | 167,460) |
| Dec 31, 2014 | 57,702) | 169,274) |
| Dec 31, 2013 | 56,244) | 172,101) |
| Dec 31, 2012 | 61,415) | 185,798) |
| Dec 31, 2011 | 57,728) | 188,002) |
| Dec 31, 2010 | 60,468) | 195,014) |
| Dec 31, 2009 | 61,670) | 212,949) |
| Dec 31, 2008 | 43,076) | 111,148) |
| Dec 31, 2007 | 46,849) | 115,268) |
| Dec 31, 2006 | 46,949) | 114,837) |
| Dec 31, 2005 | 41,896) | 117,565) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Pfizer Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total liabilities | Total debt | Total Pfizer Inc. shareholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2023 | 47,794) | 137,213) | 71,888) | 89,014) |
| Dec 31, 2022 | 42,138) | 101,288) | 35,829) | 95,661) |
| Dec 31, 2021 | 42,671) | 104,013) | 38,436) | 77,201) |
| Dec 31, 2020 | 25,920) | 90,756) | 39,836) | 63,238) |
| Dec 31, 2019 | 37,304) | 104,042) | 52,150) | 63,143) |
| Dec 31, 2018 | 31,858) | 95,664) | 41,740) | 63,407) |
| Dec 31, 2017 | 30,427) | 100,141) | 43,491) | 72,308) |
| Dec 31, 2016 | 31,115) | 111,776) | 42,086) | 59,544) |
| Dec 31, 2015 | 29,399) | 102,463) | 38,978) | 64,720) |
| Dec 31, 2014 | 21,631) | 97,652) | 36,682) | 71,301) |
| Dec 31, 2013 | 23,366) | 95,481) | 36,489) | 76,307) |
| Dec 31, 2012 | 28,619) | 104,120) | 37,460) | 81,260) |
| Dec 31, 2011 | 28,069) | 105,381) | 38,949) | 82,190) |
| Dec 31, 2010 | 28,609) | 106,749) | 44,033) | 87,813) |
| Dec 31, 2009 | 37,225) | 122,503) | 48,662) | 90,014) |
| Dec 31, 2008 | 27,009) | 53,408) | 17,283) | 57,556) |
| Dec 31, 2007 | 21,835) | 50,144) | 13,139) | 65,010) |
| Dec 31, 2006 | 21,389) | 43,479) | 7,980) | 71,358) |
| Dec 31, 2005 | 28,448) | 51,938) | 17,936) | 65,627) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Pfizer Inc., selected items from cash flow statement, long-term trends
US$ in millions
| 12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2023 | 8,700) | (32,278) | 26,066) |
| Dec 31, 2022 | 29,267) | (15,783) | (14,834) |
| Dec 31, 2021 | 32,922) | (22,534) | (9,816) |
| Dec 31, 2020 | 10,586) | (4,188) | (21,640) |
| Dec 31, 2019 | 12,588) | (3,945) | (8,485) |
| Dec 31, 2018 | 15,827) | 4,525) | (20,441) |
| Dec 31, 2017 | 16,470) | (4,741) | (13,035) |
| Dec 31, 2016 | 15,901) | (7,811) | (8,921) |
| Dec 31, 2015 | 14,512) | (2,980) | (10,233) |
| Dec 31, 2014 | 16,883) | (5,654) | (9,986) |
| Dec 31, 2013 | 17,765) | (10,625) | (14,975) |
| Dec 31, 2012 | 17,054) | 6,154) | (15,999) |
| Dec 31, 2011 | 20,240) | 2,200) | (20,607) |
| Dec 31, 2010 | 11,454) | (492) | (11,174) |
| Dec 31, 2009 | 16,587) | (31,272) | 14,481) |
| Dec 31, 2008 | 18,238) | (12,835) | (6,560) |
| Dec 31, 2007 | 13,353) | 795) | (12,610) |
| Dec 31, 2006 | 17,594) | 5,101) | (23,100) |
| Dec 31, 2005 | 14,733) | (5,072) | (9,222) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Pfizer Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2023 | 0.38 | 0.37 | 1.65 |
| Dec 31, 2022 | 5.59 | 5.47 | 1.61 |
| Dec 31, 2021 | 3.92 | 3.85 | 1.57 |
| Dec 31, 2020 | 1.73 | 1.71 | 1.53 |
| Dec 31, 2019 | 2.92 | 2.87 | 1.46 |
| Dec 31, 2018 | 1.90 | 1.87 | 1.38 |
| Dec 31, 2017 | 3.57 | 3.52 | 1.30 |
| Dec 31, 2016 | 1.18 | 1.17 | 1.22 |
| Dec 31, 2015 | 1.13 | 1.11 | 1.14 |
| Dec 31, 2014 | 1.44 | 1.42 | 1.06 |
| Dec 31, 2013 | 3.23 | 3.19 | 0.96 |
| Dec 31, 2012 | 1.96 | 1.94 | 0.88 |
| Dec 31, 2011 | 1.28 | 1.27 | 0.80 |
| Dec 31, 2010 | 1.03 | 1.02 | 0.72 |
| Dec 31, 2009 | 1.23 | 1.23 | 0.80 |
| Dec 31, 2008 | 1.20 | 1.20 | 1.28 |
| Dec 31, 2007 | 1.18 | 1.17 | 1.16 |
| Dec 31, 2006 | 2.67 | 2.66 | 0.96 |
| Dec 31, 2005 | 1.10 | 1.09 | 0.76 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.